Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.
about
Effect of Dietary Docosahexaenoic Acid Supplementation on the Participation of Vasodilator Factors in Aorta from Orchidectomized Rats.Combination of β Adrenergic Receptor Block and Renin-Angiotensin System Inhibition Diminished the Angiotensin II-Induced Vasoconstriction and Increased Bradykinin-Induced Vasodilation in Hypertension.
P2860
Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@ast
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@en
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@nl
type
label
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@ast
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@en
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@nl
prefLabel
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@ast
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@en
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@nl
P2093
P2860
P356
P1476
Clinical utility of fixed-dose ...... ential of nebivolol/valsartan.
@en
P2093
Carlos M Ferrario
Henry Punzi
Jasmina Varagic
P2860
P356
10.2147/IBPC.S50954
P407
P577
2014-11-26T00:00:00Z